慢性阻塞性肺疾病合并焦虑抑郁状态的研究现状及治疗进展  

Research status and treatment progress of chronic obstructive pulmonary disease complicated with anxiety and depression

作　　者：侯峥 王宛莹 李静[1] 马天元 卜小宁[1] Hou Zheng;Wang Wanying;Li Jing;Ma Tianyuan;Bu Xiaoning(Department of Respiratory and Critical Care Medicine,Beijing Chao-Yang Hospital,Capital Medical University,Beijing Institute of Respiratory Medicine,Beijing 100020,China)

机构地区：[1]首都医科大学附属北京朝阳医院呼吸与危重症医学科北京呼吸疾病研究所,北京100020

出　　处：《国际呼吸杂志》2022年第8期613-617,共5页International Journal of Respiration

基　　金：北京市首都卫生科研发展专项(2018-2-1062)。

摘　　要：焦虑、抑郁是慢性阻塞性肺疾病的常见合并症,可增加患者病死率,降低患者生活质量和预后,并增加急性加重的风险。对其进行全面深入的认识,有利于更加全面地评估慢性阻塞性肺疾病患者的病情并提供最佳的治疗,改善症状和预后。该文综述慢性阻塞性肺疾病患者合并焦虑、抑郁状态的研究现状及治疗进展,以期为临床选择治疗方法提供参考。Anxiety and depression are common complications of chronic obstructive pulmonary disease,which can increase the mortality,reduce the quality of life and prognosis of patients,and increase the risk of acute exacerbation.A comprehensive and in-depth understanding of it is conducive to a more comprehensive assessment of the condition of patients with chronic obstructive pulmonary disease and can provide the best treatment to improve the symptoms and prognosis.This article reviews the research status and treatment progress of anxiety and depression in patients with chronic obstructive pulmonary disease,so as to provide reference for clinical treatment selection.

关 键 词：肺疾病 慢性阻塞性 焦虑 抑郁 

分 类 号：R563.9[医药卫生—呼吸系统]